ExpreS2ion Biotech – Potential value of COVID-19 vaccine candidate

Watch as we, along with CEO Bent Frandsen, take a deeper dive into the economics and potential of ExpreS2ion on their Coronavirus vaccine candidate, including milestone and license royalty payments.

ExpreS2ion Biotechnologies is a Danish biotech company with a growing product development pipeline that is being developed together with industrial and academic partners, and includes vaccines and vaccine-like treatments for diseases such as COVID-19, breast cancer, influenza, and malaria.